康缘品牌怎么样 申请店铺

我要投票 康缘在中草药行业中的票数:378 更新时间:2025-06-17
康缘是哪个国家的品牌?「康缘」是 江苏康缘药业股份有限公司 旗下著名品牌。该品牌发源于江苏,由创始人肖伟在1996期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力康缘品牌出海!将品牌入驻外推网,定制康缘品牌推广信息,可以显著提高康缘产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

康缘怎么样

充满活力的创新型制药企业--江苏康缘药业股份有限公司是一家集中药研发、生产、贸易为一体的大型中药企业,是国家中药现代化示范企业、国家重点高新技术企业、国内A股上市公司、国家创新型企业,全国制药工业百强企业,获国家“质量管理先进企业”,“守合同重信用企业”等荣誉称号,“康缘”商标为国家驰名商标。

公司坚持以科研创新为先导,不断提升企业自主创新实力。企业设立博士后科研工作站、江苏省院士工作站,成立康缘现代中药研究院,拥有一支包括6名博士后、12名博士、80余名硕士在内的180多名科研人员组成的研究队伍;先后与中国医学科学院药物研究所、中科院上海有机化学研究所、大连工业大学等科研院所联合建立了十余个共建实验室,并在美国建立了创新药物研发公司,自主创新能力位居国内同行前列,发明专利授权量在同行业中名列前茅。2002年康缘药业被批准设立博士后科研工作站,2005年公司研发中心被认定为国家级企业技术中心。2010年1月康缘研究院被国家科技部批准建设“中药制药过程新技术国家重点实验室”,进入我国中医药创新体系国家队行列。

康缘药业拥有国内最大的智能化中药材提取生产线,具有年处理生药材10000吨的能力;拥有通过国家GMP验证的制剂车间,配套完善的备料中心、质量检测中心、动力中心、智能管理中心,设有硬胶囊、软胶囊、小容量注射剂、冻干粉针剂等十三条最先进的生产线,具备年生产硬胶囊12亿粒、软胶囊3.4亿粒、口服液1亿支、小容量注射剂5亿支、冻干粉针剂600万支、片剂15亿片、颗粒剂1000吨的能力。

康缘药业全力推行专业化、学术化营销,建立了一支高素质、专业化1600余人的营销队伍,在全国29个省市建立了34个销售分公司、226多个中心办事处,与全国146家医药商业公司建立了长期稳定的业务关系,产品覆盖近7000家县级以上医疗单位。

Jiangsu Kangyuan Pharmaceutical Co., Ltd., a dynamic and innovative pharmaceutical enterprise, is a large-scale Chinese medicine enterprise integrating research and development, production and trade of traditional Chinese medicine. It is a national modern demonstration enterprise of traditional Chinese medicine, a national key high-tech enterprise, A-share listed company, a national innovative enterprise, and one of the top 100 pharmaceutical enterprises in China, It has won the honorary titles of "advanced quality management enterprise", "contract abiding and trustworthy enterprise" and "Kangyuan" trademark is a national well-known trademark. The company adheres to scientific research and innovation as the guide, and constantly improves the independent innovation strength of the enterprise. The company has set up postdoctoral research station, Jiangsu academician workstation, and Kangyuan modern Chinese Medicine Research Institute. It has a research team of more than 180 researchers, including 6 postdoctoral, 12 doctors, and more than 80 masters. It has been jointly built with the Institute of medicine of Chinese Academy of Medical Sciences, Shanghai Institute of organic chemistry of Chinese Academy of Sciences, Dalian University of technology and other research institutes More than ten co built laboratories have been set up, and innovative drug R & D companies have been established in the United States. The independent innovation ability ranks in the forefront of domestic peers, and the amount of invention patent authorization ranks first in the same industry. In 2002, Kangyuan pharmaceutical was approved to set up a postdoctoral research workstation, and in 2005, the company's R & D center was recognized as a national enterprise technology center. In January 2010, Kangyuan Research Institute was approved by the Ministry of science and technology of the people's Republic of China to build the "National Key Laboratory of new technology in the pharmaceutical process of traditional Chinese medicine", and entered the ranks of the national team of Chinese medicine innovation system. Kangyuan Pharmaceutical Co., Ltd. has the largest intelligent production line of Chinese herbal medicine extraction in China, with an annual capacity of 10000 tons of raw herbs. It has a preparation workshop certified by the national GMP, a complete set of material preparation center, quality inspection center, power center, intelligent management center, and 13 most advanced production lines, including hard capsule, soft capsule, small volume injection, freeze-dried powder injection, It has the annual production capacity of 1.2 billion hard capsules, 340 million soft capsules, 100 million oral liquids, 500 million small volume injections, 6 million lyophilized powder injections, 1.5 billion tablets and 1000 tons of granules. Kangyuan pharmaceutical industry has made great efforts to promote professional and academic marketing, established a high-quality and professional marketing team of more than 1600 people, established 34 sales branches and more than 226 central offices in 29 provinces and cities across the country, established long-term and stable business relations with 146 pharmaceutical commercial companies across the country, with products covering nearly 7000 medical units above the county level.

本文链接: https://brand.waitui.com/0310949a5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

泡泡玛特已为珠宝品牌popop申请商标

36氪获悉,近日,泡泡玛特旗下的独立珠宝品牌popop北京首店在北京国贸商城正式开业,而在前一天,popop刚刚在上海港汇恒隆广场开出全球首店。popop作为泡泡玛特孵化的独立珠宝品牌,主打IP潮流珠宝与日常穿搭饰品的结合。爱企查App显示,北京泡泡玛特文化创意有限公司已申请注册多枚“popop”商标,国际分类涉及广告销售、珠宝钟表、科学仪器等,目前上述商标部分已注册成功。

56分钟前

宝能汽车声明:公司经营正常,且有新车即将上市

36氪获悉,宝能汽车今日发布声明称,近期,有部分媒体严重歪曲事实,恶意报道公司及关联公司发布了解散、清算公告,扰乱了网络秩序,严重侵害了公司的合法声誉,在此,公司郑重声明如下:1、部分公司虽然在国家信用信息公示平台上显示为“该企业已发布解散公示”“该企业已发布清算组备案信息”“该企业正在进行营业执照作废声明”等,但公司一切经营正常,且有新车新即将上市!虽然公司部分董事、监事等高级管理人员已离职,但并不影响公司的正常运作和经营,公司一切业务不受任何影响均在正常开展。

56分钟前

优酷在成都成立酷漫文化传媒新公司

36氪获悉,爱企查App显示,近日,成都酷漫文化传媒有限公司成立,法定代表人为谷宇,注册资本500万元人民币,经营范围包括组织文化艺术交流活动、文艺创作、数字广告制作等。股权穿透图显示,该公司由优酷网络技术(北京)有限公司全资持股。

56分钟前

港股创新药板块午后持续下挫,先声药业跌近12%

36氪获悉,截至发稿,港股创新药板块午后持续下挫,先声药业跌近12%,石药集团跌超6%。

56分钟前

河南:支持国有企业与链主企业以市场化方式合作设立天使基金和并购基金

36氪获悉,河南省人民政府发布《关于新时期推动招商引资高质量发展的指导意见》,其中提出,深入开展基金招商。聚焦培育中长期投资者和耐心资本,持续扩大政府母基金规模,支持具备条件的国有企业设立市场化母基金,与优秀投资机构合作,推动基金投早、投小、投硬科技。2025年年底前,各地原则上搭建完成本级政府母基金体系,建立招商项目资本合作响应机制。支持国有企业与链主企业以市场化方式合作设立天使基金和并购基金,充分发挥政府投资基金作用,对上下游企业进行早期孵化和战略重组。

56分钟前

本页详细列出关于康缘的品牌信息,含品牌所属公司介绍,康缘所处行业的品牌地位及优势。
咨询